President Donald Trump took to Twitter early Friday to announce that he and First Lady Melania Trump had both tested positive for COVID-19. He stated they will both begin their quarantine and recovery process immediately. 

The development comes days after he appeared at the first presidential debate with Democratic opponent Joe Biden in Ohio. 

The First Lady stated on Twitter, “We are feeling good & I have postponed all upcoming engagements. Please be sure you are staying safe & we will all get through this together.”

Friday afternoon, she updated her status once again on Twitter writing, “Thank you for the love you are sending our way. I have mild symptoms but overall feeling good. I am looking forward to a speedy recovery.”

The New York Times reported:

“It is not yet clear when and how Mr. Trump contracted the virus. The President and the first lady said they had both tested positive hours after one of his closest aides, Hope Hicks, also tested positive. Ms. Hicks received the diagnosis after she began experiencing symptoms on Wednesday while attending the President’s rally in Minnesota.”

In a memo issued to reporters around 1 a.m. ET, the President’s physician, Navy Cmdr. Dr. Sean Conley wrote:

I release the following information with the permission of President Donald J. Trump and First Lady Melania Trump.

This evening I received confirmation that both President Trump and First Lady Melania Trump have tested positive for the SARS-CoV-2 virus.

The President and First Lady are both well at this time, and they plan to remain at home within the White House during their convalescence.

The White House medical team and I will maintain a vigilant watch, and I appreciate the support provided by some of our country’s greatest medical professionals and institutions.

Rest assured, I expect the President to continue carrying out his duties without disruption while recovering, and I will keep you updated on any future developments.

The positive test now puts into question the nature of the remaining 32 days of the presidential campaign, including the remaining two presidential debates. The next one is scheduled for Oct. 15 in Miami.

On Monday, President Trump announced from the White House Rose Garden, “I’m pleased to report we’re announcing our plan to distribute 150 million Abbott point of care tests in the coming weeks.” The 150 million rapid tests are intended for “states and territories to support efforts to reopen their economies and schools” and “to protect vulnerable communities,” according to the President. 

The Guardian has reported, “The White House uses the Abbott ID Now test, which has been found to produce a significant percentage of false negatives.”

Will the President and First Lady seek further tests to rule out false positives? Have they done so already? 

Follow The HighWire on Twitter for future updates.

Derek Kramer

Other Headlines

Coronavirus

ICAN Releases Recordings of FDA’s Peter Marks; Vaccine Official Dismissed Vaccine Injuries

The Informed Consent Action Network (ICAN) and REACT 19 held a joint press conference today to reveal a trove of secret recordings and FOIA documents of Peter Marks, the former Director of the Center for Biologics Evaluation and Research. The press conference included ICAN Founder Del Bigtree, Attorney Aaron Siri, and REACT 19’s Brianne Dressen.Continue reading ICAN Releases Recordings of FDA’s Peter Marks; Vaccine Official Dismissed Vaccine Injuries

More news about Coronavirus

Health & Nutrition

New Fluoride Study Ignores Neurotoxicity and Sugar Intake in Cost Analysis

A new fluoride study has been criticized for being a tool of the industry to promote continued water fluoridation following the banning of the practice in Utah and Florida. The authors conducted a simulation model and cost-effectiveness analysis with data from 8484 children with a mean age of 9.6 years. The authors concluded eliminating fluorideContinue reading New Fluoride Study Ignores Neurotoxicity and Sugar Intake in Cost Analysis

More news about Health & Nutrition

Vaccines

HHS Terminates Moderna Contract For Bird Flu Vaccine; Calls mRNA Technology “Under-Tested”

HHS has terminated a $766 million contract with Moderna to develop an mRNA bird flu vaccine. HHS spokesman Andrew Nixon said the decision is about “safety, integrity, and trust.” He added that “mRNA technology remains under-tested, and we are not going to spend taxpayer dollars repeating the mistakes of the last administration, which concealed legitimateContinue reading HHS Terminates Moderna Contract For Bird Flu Vaccine; Calls mRNA Technology “Under-Tested”

More news about Vaccines

Science & Tech

Humanoid Robots Malfunction and Attack; Sparks Debate Over AI Safety and Liability

A viral video released from an undisclosed Chinese factory shows a humanoid robot malfunctioning and attacking the factory workers. The Unitree H1, a product of the Chinese company Unitree Robotics, can be seen flailing its arms as workers move away to protect themselves. The robot was hung on a crane, and the workers were notContinue reading Humanoid Robots Malfunction and Attack; Sparks Debate Over AI Safety and Liability

More news about Science & Tech

Environment

CDC Advised Health Care Providers Not to Test East Palestine Residents for Chemical Illnesses, Lawsuit Alleges

Newsnation reported this week that the CDC advised local health care providers in East Palestine, OH, not to test local residents for chemical illnesses after the town was exposed to a toxic plume from a “controlled burn” after the Norfolk Southern train derailment in 2023. A lawsuit has been filed against Norfolk Southern and moreContinue reading CDC Advised Health Care Providers Not to Test East Palestine Residents for Chemical Illnesses, Lawsuit Alleges

More news about Environment

Policy

HHS and CMS Urge Changes to Gender-Affirming Care for Minors; Clinics Face Potential Loss of Federal Funding

HHS Secretary Robert F. Kennedy Jr. wrote a letter addressed to healthcare providers saying he expects them to update their “treatment protocols and training to ensure that care for children with gender dysphoria is evidence-based.” The letter was also addressed to healthcare risk managers and state medical boards. The letter refers to the report publishedContinue reading HHS and CMS Urge Changes to Gender-Affirming Care for Minors; Clinics Face Potential Loss of Federal Funding

More news about Policy